biontech-pfizer
Is this your brand? Claim it — free, and takes a minute with your work email.
Overview
Tagline Brand's website · 2026-10-04
Market leadership as the most administered COVID-19 vaccine, advanced mRNA technology, available in convenient prefilled syringes, and comprehensive support resources for healthcare professionals from a globally recognized pharmaceutical leader.
Description Brand's website · 2026-10-04
BioNTech-Pfizer is a collaboration that developed and markets COMIRNATY, an mRNA COVID-19 vaccine. The scraped content focuses on providing comprehensive information, dosing guidelines, real-world evidence, and resources for U.S. healthcare professionals regarding COMIRNATY to help protect eligible individuals against severe outcomes from COVID-19.
Offerings
Core capabilities Brand's website · 2026-10-04
- COMIRNATY (COVID-19 Vaccine
- mRNA) for individuals 5 years and older.
Pricing Brand's website · 2026-10-04
Not explicitly detailed, but implies a B2B model for healthcare providers/institutions ordering vaccines, with patient assistance programs for end-users.
Audience
Target industry Brand's website · 2026-10-04
U.S. healthcare professionals (prescribers and vaccine administrators); eligible patients (65 years and older, or 5-64 years with at least one underlying high-risk condition).
Landscape
Competitors Brand's website · 2026-10-04
- Moderna
- Johnson & Johnson
- Novavax
Is this your business?
The information above is publicly sourced — assembled by Optimly from biontech-pfizer's website and public pages.
Claim this profile to publish your own verified Business Profile and speak for biontech-pfizer across the index.
Claim biontech-pfizer — free →Page last updated 2026-10-17.